Results 231 to 240 of about 267,153 (398)

The COVID-19 Serology Studies Workshop: Recommendations and Challenges

open access: yesImmunity, 2020
Andrea M. Lerner   +6 more
semanticscholar   +1 more source

Central Nervous System Involvement as the Initial Manifestation of Transthyretin Amyloidosis: A Case Report and Literature Review

open access: yesiRADIOLOGY, EarlyView.
We reported a patient who presented with transient focal neurological symptoms. The contrast‐enhanced brain magnetic resonance imaging (MRI) of this patient demonstrated significant enhancement of the dura mater, pia mater, and spinal meninges. Based on the positive result of single photon emission computed tomography (SPECT), we promptly determined ...
Fen Li   +6 more
wiley   +1 more source

Characterization of PIVKA‐II Molecular Forms via Size Exclusion Chromatography and Hydrophobic Interaction Chromatography in HCC Patients

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
PIVKA‐II comprises two heterogeneous molecular forms with different levels regarding hydrophobicity, and PIVKA‐II in serum and plasma exists as distinct molecular forms with varying levels. ABSTRACT Background Protein induced by the absence of vitamin K or antagonist‐II (PIVKA‐II) is an important serological biomarker for the diagnosis of ...
Yoshiyuki Kitamura, Katsumi Aoyagi
wiley   +1 more source

The Proportion of <i>Treponema pallidum</i> Polymerase Chain Reaction-Positive Primary Syphilis Infections That Are Seronegative for Syphilis: A Systematic Review and Meta-analysis. [PDF]

open access: yesOpen Forum Infect Dis
Hughes Y   +11 more
europepmc   +1 more source

The serology of experimental Salmonella dublin infections of cattle [PDF]

open access: bronze, 1978
G.A. Hall   +3 more
openalex   +1 more source

A Proposal for a Serology-Based Approach to Membranous Nephropathy.

open access: yesJournal of the American Society of Nephrology, 2017
A. D. De Vriese   +4 more
semanticscholar   +1 more source

Pharmacokinetics and Safety of Fezolinetant in Women with Hepatic or Renal Impairment

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract The neurokinin 3 receptor antagonist fezolinetant is an approved treatment for vasomotor symptoms due to menopause. The impacts of hepatic and renal impairment on the pharmacokinetics and safety of a single oral dose of fezolinetant 30 mg were investigated in two independent studies.
Megumi Iwai   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy